artificial intelligence

Medicomp CEO Dave Lareau discusses how his company made early coronavirus-specific changes to its database and AI engine as the pandemic took hold in February and has continued to innovate since then.

Dr. Nathalie Bloch, head of big data and AI at the ARC Innovation Center at Sheba Medical Center, Israel, discusses the use of AI in dealing with COVID-19 patients in this episode of The Alessi Agenda.

AI is steadily proving itself to the clinical community, but there are some aspects of care in which an algorithm will never be granted full control, said Cardiologs CEO Yann Fleureau.

In this HIMSS TV Deep Dive, we show how health systems are leveraging advanced technologies such as AI, analytics and telehealth to manage patient populations while still staying focused on the basic building blocks of health and wellness.

Epstein Becker & Green's Bradley Merrill Thompson describes the agency's current trajectory for regulation of patient-facing and provider-facing telehealth products that incorporate AI.

The advantages to health and human service delivery in a bot workforce include speed, reliability, consistency and cost-effectiveness. Sound too far-fetched for your management team? We would disagree.  

The AI company now has a presence among more than 500 U.S. hospitals.

Deep Dive: From clinical decision support to revenue cycle to cybersecurity, machine learning algorithms are already transforming healthcare, although much depends on how they're implemented.

The recently announced COVID-19 Open Research Dataset consists of more than 29,000 machine-readable coronavirus articles ripe for analysis.

The collection of B2B AI companies already counts Concerto HealthAI among its numbers.